BCR-ABL1 is an abnormal gene present in certain types of leukemia. Genetic testing for BCR-ABL1 helps doctors diagnose these cancers and assess their response to treatment. If you or someone you know ...
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up A total of 962 cases of CML on ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--BCR today announced it will be rolling out a major repositioning and brand refresh this Spring which parallels a recently announced expansion to provide its ...
BCR Announces Strategic Partnership to Bring Leading Belt Dryer Brand SEVAR to North American Market
JACKSONVILLE, Fla.--(BUSINESS WIRE)--BCR Inc, a leading provider of proven biosolids and process treatment technology solutions, announced today a strategic partnership with leading Germany-based belt ...
Treatments that reduce the risk for biochemical recurrence (BCR) do not necessarily improve overall survival in men with prostate cancer, a new study finds. BCR-free survival and time to BCR are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results